Azenta provides products and services that help pharmaceutical, biotech, and academic life sciences organizations store, manage, and analyze biological and chemical samples. The company operates two segments. Sample Management Solutions (~55% of revenue) sells automated cold storage systems that function as sophisticated warehouse management systems operating at ultra-cold temperatures, complemented by sample intelligence software. For customers who want to outsource storage entirely, Azenta operates a network of bio-repositories under long-term contracts (typically 7-25 years). The segment also sells cryogenic systems, automated sample tubes, and consumables and instruments. Multiomics (~45% of revenue), operating under the GENEWIZ brand, provides genomic testing services — primarily next-generation sequencing, Sanger sequencing, gene synthesis, and bioinformatics — through a global network of 14 labs across the U.S., China, U.K., Germany, and Japan. Azenta serves roughly 14,000 customers globally, selling primarily through a direct sales force. The business model blends capital equipment sales (lumpy, project-based) with recurring revenue from long-term storage contracts, consumables, and genomic services. Once an automated store or instrument is installed, consumables and service attachment is nearly 100%, creating a durable recurring revenue tail. Azenta's growth strategy focuses on expanding its commercial headcount, enforcing contractual price escalators in its storage contracts, and pursuing tuck-in M&A in bio-repository scale, automated solutions, and gene synthesis.